Streamline Health Solutions (NASDAQ:STRM) Research Coverage Started at StockNews.com

StockNews.com began coverage on shares of Streamline Health Solutions (NASDAQ:STRM) in a research report report published on Wednesday. The firm issued a sell rating on the stock.

Separately, Craig Hallum upgraded shares of Streamline Health Solutions to a “strong-buy” rating in a report on Thursday, September 5th.

Streamline Health Solutions Trading Up 1.2 %

Shares of STRM opened at $3.29 on Wednesday. Streamline Health Solutions has a fifty-two week low of $1.85 and a fifty-two week high of $9.75. The firm has a market cap of $13.90 million, a price-to-earnings ratio of -0.66 and a beta of 1.67. The firm has a 50 day moving average price of $2.61 and a 200-day moving average price of $5.25. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.61 and a current ratio of 0.61.

Streamline Health Solutions (NASDAQ:STRM) last posted its quarterly earnings results on Wednesday, September 11th. The company reported ($0.75) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.60) by ($0.15). The business had revenue of $4.48 million for the quarter. Streamline Health Solutions had a negative net margin of 92.72% and a negative return on equity of 44.85%.

Streamline Health Solutions Company Profile

Streamline Health Solutions, Inc offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management.